The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

A team of researchers led by Dr. KIM V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...

The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

HKU State Key Laboratory for Emerging Infectious Diseases and InnoHK Centre for Virology, Vaccinology and Therapeutics Successfully Develop Nasal ...

The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...